Yau T, Zagonel V, Santoro A, Acosta-Rivera M, et al. Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. J Clin Oncol 2022 Dec 13:JCO2200972. doi: 10.1200/JCO.22.00972.
PMID: 36512738